Widely used by the food industry, emulsifiers – a type of food additive – are found in many daily foods (sliced bread, ice ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects.

mefloquine-sensitive) were simultaneously tested for the same drugs for comparison. Isolates were considered of low sensitivity to quinine, halofantrine or mefloquine if their IC 50s were higher than ...

Named ErSo-TFPy, this drug shows remarkable results in preclinical studies on various human ER+ breast cancer cell lines and animal models. Scientists have developed a promising single-dose ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

It’s true to say that drug usage has a variety of negative consequences for its users and, on the whole, governments are right to advise against it. People in New York who smoke cannabis should ...

You may receive a combination of therapies or something else entirely. Oncology (cancer) drugs include a range of therapies and medications, such as chemotherapy drugs, targeted therapies ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive studies-of ...

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...

For drug-sensitive TB, patients can benefit from regimens that cut treatment time by a third, while the all-oral 6-month regimens for drug-resistant TB are safer and more effective than older ...

Celiac disease is an autoimmune condition that causes a severe immune response to gluten. A gluten allergy is different from a gluten sensitivity or intolerance. A gluten allergy develops when the ...